362 related articles for article (PubMed ID: 24396504)
21. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
Roy B; Lee E; Li T; Rampersaud M
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
[TBL] [Abstract][Full Text] [Related]
22. The Role of MicroRNAs in Spinocerebellar Ataxia Type 3.
Krauss S; Evert BO
J Mol Biol; 2019 Apr; 431(9):1729-1742. PubMed ID: 30664869
[TBL] [Abstract][Full Text] [Related]
23. Unlocking the door to new therapies in cardiovascular disease: microRNAs hold the key.
Nguyen MA; Karunakaran D; Rayner KJ
Curr Cardiol Rep; 2014 Nov; 16(11):539. PubMed ID: 25303893
[TBL] [Abstract][Full Text] [Related]
24. Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.
Weinberg MS; Wood MJ
Hum Mol Genet; 2009 Apr; 18(R1):R27-39. PubMed ID: 19297399
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs in neurodegenerative disorders.
Junn E; Mouradian MM
Cell Cycle; 2010 May; 9(9):1717-21. PubMed ID: 20404550
[TBL] [Abstract][Full Text] [Related]
26. microRNA dysregulation in neurodegenerative diseases: A systematic review.
Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
[TBL] [Abstract][Full Text] [Related]
27. Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.
Du L; Pertsemlidis A
J Mol Cell Biol; 2011 Jun; 3(3):176-80. PubMed ID: 21278200
[TBL] [Abstract][Full Text] [Related]
28. Neurodegenerative Disorders Treatment: The MicroRNA Role.
Ridolfi B; Abdel-Haq H
Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA in central nervous system trauma and degenerative disorders.
Liu NK; Xu XM
Physiol Genomics; 2011 May; 43(10):571-80. PubMed ID: 21385946
[TBL] [Abstract][Full Text] [Related]
30. microRNAs: innovative targets for cerebral ischemia and stroke.
Ouyang YB; Stary CM; Yang GY; Giffard R
Curr Drug Targets; 2013 Jan; 14(1):90-101. PubMed ID: 23170800
[TBL] [Abstract][Full Text] [Related]
31. Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story.
Ala U
Cells; 2020 Jun; 9(7):. PubMed ID: 32605220
[TBL] [Abstract][Full Text] [Related]
32. microRNA therapeutics in cardiovascular disease models.
Dangwal S; Thum T
Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
[TBL] [Abstract][Full Text] [Related]
33. Pinpointing miRNA and genes enrichment over trait-relevant tissue network in Genome-Wide Association Studies.
Li B; Dong J; Yu J; Fan Y; Shang L; Zhou X; Bai Y
BMC Med Genomics; 2020 Dec; 13(Suppl 11):191. PubMed ID: 33371893
[TBL] [Abstract][Full Text] [Related]
34. Role of miRNAs in human disease and inborn errors of metabolism.
Rivera-Barahona A; Pérez B; Richard E; Desviat LR
J Inherit Metab Dis; 2017 Jul; 40(4):471-480. PubMed ID: 28229250
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of differentially-regulated hepatic microRNAs identifies candidate post-transcriptional regulation networks of intermediary metabolism in rainbow trout.
Kostyniuk DJ; Mennigen JA
Comp Biochem Physiol Part D Genomics Proteomics; 2020 Dec; 36():100750. PubMed ID: 33038710
[TBL] [Abstract][Full Text] [Related]
36. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
[TBL] [Abstract][Full Text] [Related]
37. Shielding the messenger (RNA): microRNA-based anticancer therapies.
Sotillo E; Thomas-Tikhonenko A
Pharmacol Ther; 2011 Jul; 131(1):18-32. PubMed ID: 21514318
[TBL] [Abstract][Full Text] [Related]
38. miRNA and vascular cell movement.
Yue J
Adv Drug Deliv Rev; 2011 Jul; 63(8):616-22. PubMed ID: 21241758
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases.
Li S; Liang Z; Xu L; Zou F
Mol Cell Biochem; 2012 Jan; 360(1-2):147-58. PubMed ID: 21909994
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.
Nana-Sinkam SP; Croce CM
IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
